HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a report issued on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, Q3 […]
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Precigen Stock Performance NASDAQ PGEN opened at $1.38 on Tuesday. The company’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.32. Precigen has a 52-week low […]
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by stock analysts at StockNews.com to a “sell” rating in a research report issued on Tuesday. Precigen Price Performance Shares of PGEN opened at $1.38 on Tuesday. The firm has a fifty day simple moving average of $1.30 and a two-hundred day simple moving average of $1.32. […]